Boyd R Viers1, Sandhya Pruthi2, Marcelino E Rivera1, Daniel A O'Neil3, Matthew R Gardner3, Sarah M Jenkins4, Deborah J Lightner1, Matthew T Gettman5. 1. Department of Urology, Mayo Clinic, Rochester, MN. 2. Center for Innovation, Mayo Clinic, Rochester, MN; Department of Internal Medicine, Mayo Clinic, Rochester, MN. 3. Center for Innovation, Mayo Clinic, Rochester, MN. 4. Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN. 5. Department of Urology, Mayo Clinic, Rochester, MN. Electronic address: Gettman.matthew@mayo.edu.
Abstract
OBJECTIVE: To examine patient preuse acceptance and perceptions of video visit (VV) technology within an ambulatory urology setting. METHODS: Patients treated by a single urology department from January to June 2013 were identified. A Web-based survey was conducted evaluating patient demographics, preuse perceptions, and acceptance of VV. RESULTS: In total, 1378 patients (25%) completed the survey; of which 868 (63%) were willing to participate in VV for their urologic care. Compared with patients "unlikely," those "likely" to participate in VV were younger (62 vs 65 years), had a college education (77% vs 65%), had previous exposure to videoconference technology (57% vs 38%), were more comfortable discussing new symptoms (56% vs 30%) and sensitive information (48% vs 27%), and played an active role in their healthcare (65% vs 54%). Moreover, patients willing to participate in VV traveled larger distances (>90 minutes; 69% vs 58%), missed more work (>1 day; 39% vs 29%), and incurred greater expenses for their care (>$250; 52% vs 25%) relative to those who were unlikely. After controlling for associated patient characteristics, a high level of agreement among urology-specific questions remained independently associated with greater likelihood of VV acceptance among both male and female patients. CONCLUSION: A large proportion of patients are willing to participate in VV for their urologic care. This may have significant implications by reducing costs and increasing access to, and quality of, health care services. These findings may assist urologists in strategically directing future efforts to reach diverse patient populations via VV technology.
OBJECTIVE: To examine patient preuse acceptance and perceptions of video visit (VV) technology within an ambulatory urology setting. METHODS:Patients treated by a single urology department from January to June 2013 were identified. A Web-based survey was conducted evaluating patient demographics, preuse perceptions, and acceptance of VV. RESULTS: In total, 1378 patients (25%) completed the survey; of which 868 (63%) were willing to participate in VV for their urologic care. Compared with patients "unlikely," those "likely" to participate in VV were younger (62 vs 65 years), had a college education (77% vs 65%), had previous exposure to videoconference technology (57% vs 38%), were more comfortable discussing new symptoms (56% vs 30%) and sensitive information (48% vs 27%), and played an active role in their healthcare (65% vs 54%). Moreover, patients willing to participate in VV traveled larger distances (>90 minutes; 69% vs 58%), missed more work (>1 day; 39% vs 29%), and incurred greater expenses for their care (>$250; 52% vs 25%) relative to those who were unlikely. After controlling for associated patient characteristics, a high level of agreement among urology-specific questions remained independently associated with greater likelihood of VV acceptance among both male and female patients. CONCLUSION: A large proportion of patients are willing to participate in VV for their urologic care. This may have significant implications by reducing costs and increasing access to, and quality of, health care services. These findings may assist urologists in strategically directing future efforts to reach diverse patient populations via VV technology.
Authors: Andrew C Griggs; Crystal M Fausett; Richard J Simonson; Kimberly N Williams; Tiffany M Bisbey; Elizabeth H Lazzara; Joseph R Keebler; Deborah DiazGranados; Vimal K Mishra; Eric J Thomas; Eduardo Salas Journal: Hum Factors Healthc Date: 2022-04-08
Authors: Zaid Bilgrami; Ameer Abutaleb; Kenechukwu Chudy-Onwugaje; Patricia Langenberg; Miguel Regueiro; David A Schwartz; J Kathleen Tracy; Leyla Ghazi; Seema A Patil; Sandra M Quezada; Katharine M Russman; Charlene C Quinn; Guruprasad Jambaulikar; Dawn B Beaulieu; Sara Horst; Raymond K Cross Journal: Dig Dis Sci Date: 2019-01-02 Impact factor: 3.199
Authors: David S Portney; Rohan Ved; Vahagn Nikolian; Andrea Wei; Tom Buchmueller; Brad Killaly; Hasan B Alam; Chad Ellimoottil Journal: Mhealth Date: 2020-10-05